Science Explorer Interactive view Map
Nonprofit · London · United Kingdom

Ovarian Cancer Action

ovarian.org.ukROR OpenAlex
Research works
43
▼ 58% vs 2013–17
Citations
1.9k
44.1 per fractional work
Top-10% rate
36.5%
record average 16.5%
Open access
60%
world 28%

Not ranked overall: Ovarian Cancer Action is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.36× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.91× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.24× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.32× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.07× its world share, 0 worksComputer ScienceMathematics: 0.31× its world share, 0 worksMathematicsMedicine: 2.66× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 0.93× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.21× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.9×. Every wedge is a field page.

Which keywords describe research at Ovarian Cancer Action?

By fractional works in all years, weighted toward what it does more of than the world: Metastasis, Ovarian Cancer, Chemotherapy, Cytoreductive Surgery, Biomarkers, Clinical Trials, Genomic Analysis and Mutation Analysis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Metastasis8▲ 59×7 topics
  2. Ovarian Cancer8▲ 213×3 topics
  3. Chemotherapy8▲ 27×12 topics
  4. Cytoreductive Surgery8▲ 284×2 topics
  5. Biomarkers8▲ 29×5 topics
  6. Clinical Trials8▲ 28×5 topics
  7. Genomic Analysis7▲ 58×2 topics
  8. Mutation Analysis7▲ 222×1 topic
  9. Tumor Models7▲ 272×1 topic
  10. Cancer6▲ 9.7×25 topics
  11. Cancer Therapy4▲ 13×9 topics
  12. Cell Death3▲ 32×5 topics
  13. Homologous Recombination3▲ 96×2 topics
  14. Synthetic Lethality2▲ 223×2 topics
  15. DNA Repair2▲ 226×2 topics
  16. BRCA Mutation2▲ 306×1 topic
  17. PARP Inhibitors2▲ 306×1 topic
  18. Survival Analysis2▲ 18×4 topics
  19. Gene Expression2▲ 7.4×8 topics
  20. Tumor Microenvironment2▲ 12×7 topics
  21. Breast Cancer2▲ 14×7 topics
  22. Genomic Instability2▲ 32×2 topics
  23. Targeted Therapy2▲ 19×4 topics
  24. Immunotherapy2▲ 5.7×9 topics
  25. Inflammation2▲ 1.61×15 topics
  26. DNA Methylation2▲ 29×1 topic
  27. Epigenetic Regulation2▲ 16×4 topics
  28. Histone Modification2▲ 52×1 topic
  29. Precision Medicine2▲ 11×5 topics
  30. Cancer Risk1▲ 12×2 topics
  31. Genetic Testing1▲ 20×2 topics
  32. Clinical Practice Guidelines1▲ 5.4×5 topics
  33. Cancer Genomics1▲ 52×1 topic
  34. Cell-Free DNA1▲ 31×2 topics
  35. Mutational Signatures1▲ 52×1 topic
  36. Transcriptional Regulation1▲ 11×6 topics
  37. BRCA11▲ 102×1 topic
  38. BRCA21▲ 102×1 topic
  39. Cervical Cancer1▲ 25×2 topics
  40. Robotic Surgery1▲ 17×2 topics

Which research topics does Ovarian Cancer Action publish most on?

By volume in 2022–2025: Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics and CRISPR and Genetic Engineering.

Ovarian cancer diagnosis…1Ovarian cancer diagnosis and treatment: 1 fractional worksPARP inhibition in cance…0PARP inhibition in cancer therapy: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksCRISPR and Genetic Engineering: 0 fractional worksCancer-related gene regulation: 0 fractional worksEpigenetics and DNA Meth…0Epigenetics and DNA Methylation: 0 fractional worksRadiomics and Machine Learning in Medical Imaging: 0 fractional worksFamily Support in Illness: 0 fractional worksRNA Research and Splicing: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional works
Reproductive MedicineOncologyCancer ResearchMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
  2. 2 PARP inhibition in cancer therapy Oncology 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 CRISPR and Genetic Engineering Molecular Biology 0 works
  5. 5 Cancer-related gene regulation Molecular Biology 0 works
  6. 6 Epigenetics and DNA Methylation Molecular Biology 0 works
  7. 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Family Support in Illness Sociology and Political Science 0 works
  9. 9 RNA Research and Splicing Molecular Biology 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.5%not open40.5%

World: 28% of research is openly available.

with international co-authors44.6%domestic only55.4%

World: 19% is written across borders.

How has Ovarian Cancer Action's research output changed?

Output in 2018–2022 was 58% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.